发明名称 Methods and compositions for the treatment of cancer or other diseases
摘要 The present invention relates to methods and compositions for the treatment of diseases, including cancer, infectious diseases and autoimmune diseases. The present invention also relates to methods and compositions for improving immune function. More particularly, the present invention relates to multifunctional molecules that are capable of being delivered to cells of interest for the treatment of diseases and for the improvement in immune function.
申请公布号 US9200279(B2) 申请公布日期 2015.12.01
申请号 US201414154833 申请日期 2014.01.14
申请人 CITY OF HOPE 发明人 Yu Hua;Kortylewski Marcin;Jove Richard;Swiderski Piotr Marek;Rossi John J.
分类号 C07H21/02;C07H21/04;A61K48/00;C12N15/11;C12N15/113;A61K31/7105;A61K31/713;A61K47/48;C07K14/47 主分类号 C07H21/02
代理机构 Rothwell, Figg, Ernst & Manbeck P.C. 代理人 Rothwell, Figg, Ernst & Manbeck P.C.
主权项 1. A method of treating a disease which comprises administering a therapeutically effective amount of a molecule to an individual in need thereof, wherein the disease is one that can be treated by regulating the Stat3 pathway or genes under control of Stat3, wherein the molecule comprises a modified human STAT3 sense strand and a human CpG(D19)-STAT3 antisense strand, wherein the modified human STAT3 sense strand comprises an oligonucleotide having the nucleotides set forth in SEQ ID NO:17, wherein the modifications are selected from the group consisting of 2′F, 2′OMe, LNA, nucleotides and other modifications described herein, wherein the human CpG(D19)-STAT3 antisense strand comprises (a) a first oligonucleotide having the nucleotides set forth in SEQ ID NO:16, (b) a C3 carbon chain or propanediol linker and (c) a second oligonucleotide having the nucleotides set forth in SEQ ID NO:5 that is the antisense strand, and wherein the sense strand and the antisense strand anneal to form a double stranded siRNA.
地址 Duarte CA US